Misako M. Nagasaka
Hematology | Oncology
101 The City Drive South
Building 23
Orange, CA 92868
Building 23
Orange, CA 92868
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 213 publications
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 01, 2026
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non-Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: June 18, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.
Journal: JCO precision oncology
Published: June 08, 2026
Will the Pauper (Deulorlatinib/TGRX-326) Take the CROWN From the Prince (Lorlatinib) in an Alternate Ending? Deuteration Is Here to Stay in Oncology.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 21, 2026
Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 15, 2026
Consideration of Enrollment Rates of Asian, Asian Pacific Islander, and Hispanic Patients in Non-small Cell Lung Cancer Trials.
Journal: Targeted oncology
Published: April 30, 2026
International Consensus on Severe Lung Cancer-The Second Edition.
Journal: Translational lung cancer research
Published: March 21, 2026
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial.
Journal: The Lancet. Oncology
Published: March 20, 2026
Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life.
Journal: Lung cancer management
Published: March 05, 2026
XPO1 inhibition enhances the efficacy and durability of RAS-targeted therapy in preclinical models of KRASG12D mutant pancreatic ductal adenocarcinoma.
Journal: Cancer letters
Published: March 02, 2026
Assessment of real-world surveillance strategies for patients undergoing systemic therapy for brain metastases.
Journal: Frontiers in oncology
Published: February 23, 2026
Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma.
Journal: Journal for immunotherapy of cancer
Published: February 16, 2026
Last Updated: 09/26/2026